Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
5 drugs in development
By Therapeutic Area
top 4
R&D Momentum
85/100
Pipeline Velocity
70/100
Trial Completion Rate
53/100
Pipeline Concentration
22/100
Pipeline Freshness
61/100
Strategic Signals
Activity
Last 14 days
Retrospective Observational Study of Intensive First-Line Treatments for Adult Burkitt Lymphoma at Strasbourg University Hospitals
Long-Term Epilepsy Outcomes in Children With a History of Perinatal Stroke
Effect of Transcranial Photobiomodulation on Clinical Symptoms, Quality of Life and Cerebral Connectivity Modifications in Dementia With Lewy Bodies
Patient-Specific Biomechanical Modeling of Incisional Hernias Using Artificial Intelligence and Finite Element Analysis
Management of Relapsed or Refractory Acute Leukemia With Menin Inhibitors in Children: A French National Retrospective Study
Prehospital Care of End-of-Life Patients by the Strasbourg Mobile Emergency and Resuscitation Service (SMUR): A Qualitative Study of Healthcare Professionals' Experiences and Use of a Comfort Care Booklet
Predictors of Success and Failure of v-NOTES Hysterectomy for Large and Very Large Uteri
Characterization of CD180 Protein Expression in Myeloid Hematological Malignancies by Flow Cytometry
Single-Center Observational Study on the Validity of the D-TAP Parental Questionnaire for Early Screening of Pediatric Feeding Disorder in Hospitalized Children Aged 8 to 18 Months
Prevalence of Tick-borne Encephalitis (TBE) in the Pediatric Population Treated at the University Hospitals of Strasbourg (HUS) and Characterization of Confirmed Pediatric Cases
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)